What’s the difference between finasteride and dutasteride for hair loss, and which is appropriate in Europe?

Finasteride vs dutasteride explained: androgenetic alopecia, DHT suppression, 5-alpha reductase inhibition, efficacy data, and prescribing criteria.

In this episode, we compare finasteride and dutasteride for male pattern hair loss and clarify how doctors assess suitability under EU medical guidance.

You’ll learn:

• How both medications reduce dihydrotestosterone (DHT)

• The difference between type II inhibition (finasteride) and dual type I & II inhibition (dutasteride)

• Evidence comparing efficacy for hair density and stabilisation

• Approved indications in the EU and off-label considerations

• Potential side effects, including sexual and mood-related symptoms

• Fertility considerations and teratogenic risk

• Situations where treatment requests may be declined pending full assessment

We explain how doctors assess hair loss pattern, age, medical history, cardiovascular profile, fertility plans, previous treatment response, and side effect risk during an online consultation in the EU. Stronger DHT suppression does not automatically mean appropriate treatment for every patient.

This episode reflects the clinical standards used by Mobi Doctor, where hair loss consultations are reviewed by a registered physician in line with EU prescribing guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/dutasteride-vs-finasteride